Cannabis use, gender and age of onset of schizophrenia: Data from the ÆSOP study

[1]  Koen Van Laere,et al.  Increased ventral striatal CB1 receptor binding is related to negative symptoms in drug-free patients with schizophrenia , 2013, NeuroImage.

[2]  A. Jablensky,et al.  Age at initiation of cannabis use predicts age at onset of psychosis: the 7- to 8-year trend. , 2013, Schizophrenia bulletin.

[3]  I. Sommer,et al.  Estrogen augmentation in schizophrenia: A quantitative review of current evidence , 2012, Schizophrenia Research.

[4]  G. Doody,et al.  Effect of illegal substance use on cognitive function in individuals with a psychotic disorder: a review and meta-analysis. , 2012, Neuropsychology.

[5]  R. Murray,et al.  Gender difference in age at onset of schizophrenia: a meta-analysis , 2012, Psychological Medicine.

[6]  M. De Hert,et al.  Genetic variation underlying psychosis-inducing effects of cannabis: critical review and future directions. , 2012, Current pharmaceutical design.

[7]  J. Os,et al.  Age at onset of non-affective psychosis in relation to cannabis use, other drug use and gender , 2012, Psychological Medicine.

[8]  J. Kulkarni,et al.  Hormones and schizophrenia , 2012, Current opinion in psychiatry.

[9]  J. Kulkarni,et al.  The Role of Oestrogen and Other Hormones in the Pathophysiology and Treatment of Schizophrenia , 2012, Schizophrenia research and treatment.

[10]  R. Murray,et al.  Cannabis use in young people: The risk for schizophrenia , 2011, Neuroscience & Biobehavioral Reviews.

[11]  M. Large,et al.  Cannabis use and earlier onset of psychosis: a systematic meta-analysis. , 2011, Archives of general psychiatry.

[12]  M. Ron,et al.  The Effect of Cannabis Use and Cognitive Reserve on Age at Onset and Psychosis Outcomes in First-Episode Schizophrenia , 2011, Schizophrenia bulletin.

[13]  J. Peuskens,et al.  Effects of cannabis use on age at onset in schizophrenia and bipolar disorder , 2011, Schizophrenia Research.

[14]  Peter B. Jones,et al.  The association between substance misuse and first-episode psychosis in a defined UK geographical area during the 1990s , 2011, Social Psychiatry and Psychiatric Epidemiology.

[15]  F. Rehman.  Schedules for clinical assessment in neuropsychiatry , 2011, BMJ : British Medical Journal.

[16]  C. Depp,et al.  Is late‐onset schizophrenia a subtype of schizophrenia? , 2010, Acta psychiatrica Scandinavica.

[17]  D. Robinson,et al.  Are cannabis use disorders associated with an earlier age at onset of psychosis? A study in first episode schizophrenia , 2010, Schizophrenia Research.

[18]  F. Sarramea,et al.  Temporal relationship of first-episode non-affective psychosis with cannabis use: a clinical verification of an epidemiological hypothesis. , 2010, Journal of psychiatric research.

[19]  R. Murray,et al.  Illicit substance use and its correlates in first episode psychosis , 2010, Acta psychiatrica Scandinavica.

[20]  Alessandra Paparelli,et al.  High-potency cannabis and the risk of psychosis , 2009, British Journal of Psychiatry.

[21]  E. Walker,et al.  Association of pre-onset cannabis, alcohol, and tobacco use with age at onset of prodrome and age at onset of psychosis in first-episode patients. , 2009, The American journal of psychiatry.

[22]  B. Mulsant,et al.  Age at onset and cognition in schizophrenia: meta-analysis , 2009, British Journal of Psychiatry.

[23]  B. Crespo-Facorro,et al.  Prognostic value of cognitive functioning for global functional recovery in first-episode schizophrenia , 2009, Psychological Medicine.

[24]  B. Gutiérrez,et al.  Fewer neurological soft signs among first episode psychosis patients with heavy cannabis use , 2009, Schizophrenia Research.

[25]  M. Ron,et al.  IQ as a predictor of functional outcome in schizophrenia: A longitudinal, four-year study of first-episode psychosis , 2009, Schizophrenia Research.

[26]  E. Vieta,et al.  Impact of cannabis and other drugs on age at onset of psychosis. , 2008, The Journal of clinical psychiatry.

[27]  Peter B. Jones,et al.  Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review , 2007, The Lancet.

[28]  P. Parzer,et al.  Estrogen, menstrual cycle phases, and psychopathology in women suffering from schizophrenia , 2007, Psychological Medicine.

[29]  J. Addington,et al.  Patterns, predictors and impact of substance use in early psychosis: a longitudinal study , 2007, Acta psychiatrica Scandinavica.

[30]  J. O. Johannessen,et al.  Substance abuse in first-episode non-affective psychosis , 2006, Schizophrenia Research.

[31]  J. Rabinowitz,et al.  A population based elaboration of the role of age of onset on the course of schizophrenia , 2006, Schizophrenia Research.

[32]  Peter B. Jones,et al.  Incidence of schizophrenia and other psychoses in ethnic minority groups: results from the MRC AESOP Study , 2006, Psychological Medicine.

[33]  Paola Dazzan,et al.  Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AeSOP study. , 2006, Archives of general psychiatry.

[34]  S. Hutton,et al.  Comorbid substance use and age at onset of schizophrenia , 2006, British Journal of Psychiatry.

[35]  J. Badcock,et al.  Validity and Consistency of Self-Reports Regarding Substance Use in General Research Volunteers, Including Regular Cannabis Users and Schizophrenia Patients , 2006, Substance use & misuse.

[36]  A. Mortimer,et al.  Estrogen for schizophrenia. , 2005, The Cochrane database of systematic reviews.

[37]  N. Andreasen,et al.  Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. , 2005, The American journal of psychiatry.

[38]  R. Kahn,et al.  Cannabis use and age at onset of schizophrenia. , 2004, The American journal of psychiatry.

[39]  G. Bersani,et al.  Cannabis and Neurological Soft Signs in Schizophrenia: Absence of Relationship and Influence on Psychopathology , 2002, Psychopathology.

[40]  A. Malla,et al.  Symptoms, cognition, treatment adherence and functional outcome in first-episode psychosis , 2002, Psychological Medicine.

[41]  T. Wenzel,et al.  Guilt and Depression: A Cross-Cultural Comparative Study , 2001, Psychopathology.

[42]  P. Wise,et al.  Minireview: Neuroprotective Effects of Estrogen-New Insights into Mechanisms of Action. , 2001, Endocrinology.

[43]  P. Dingemans,et al.  Cannabis abuse and the course of recent onset schizophrenic disorders , 1993, Schizophrenia Research.

[44]  T. Craig,et al.  The Incidence of Schizophrenia in Nottingham , 1987, British Journal of Psychiatry.

[45]  H. Akaike.  A new look at the statistical model identification , 1974 .

[46]  B. Cohen,et al.  Clinical characteristics influencing age at onset in psychotic disorders. , 2009, Comprehensive psychiatry.

[47]  J. DiSantostefano,et al.  International Classification of Diseases 10th Revision (ICD-10) , 2009 .

[48]  L. DeLisi.  The significance of age of onset for schizophrenia. , 1992, Schizophrenia bulletin.

[49]  A. Korten,et al.  Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study. , 1992, Psychological medicine. Monograph supplement.

[50]  Martin Gw,et al.  Validation of self-reported cannabis use by urine analysis , 1988 .